COVID-19 – ‘Shielding’ Guidance for Children and Young People

This page provides advice to members on which paediatric patient groups are considered to be clinically extremely vulnerable during the COVID-19 outbreak and at very high risk of severe illness from coming into contact with the virus. It also provides frequently asked questions on how ‘shielding’ applies to children and families.

This updated RCPCH advice for clinicians is provided to help members in their discussions with children and young people who are shielding across the UK and their families.

This advice was initially developed in June 2020 in partnership with a wide range of paediatric specialty groups: British Association of Paediatric Nephrology, British Association of Perinatal Medicine, British Congenital Cardiac Assocation, British Inherited Metabolic Disease Group, British Paediatric Allergy, Immunity & Infection Group (working with the UK Primary Immunodeficiency Network), British Paediatric Neurology Association, British Paediatric Respiratory Society, British Society for Paediatric Endocrinology and Diabetes, British Society of Paediatric Gastroenterology, Hepatology and Nutrition, British Society for Rheumatology, Children’s Cancer and Leukaemia Group, Paediatric Special Interest Group of British Haematology Society. Many specialties also worked with parents and patient groups as they developed their advice.

Disponível Em: <https://www.rcpch.ac.uk/>